Literature DB >> 8775083

Three-dimensional sonographic guidance for interstitial laser therapy in benign prostatic hyperplasia.

H Strasser1, G Janetschek, W Horninger, G Bartsch.   

Abstract

In recent years, interstitial laser therapy was introduced to provide a new treatment of benign prostatic hyperplasia (BPH). However, the precise positioning of the laser fibers has remained a major unsettled issue. Three-dimensional (3-D) transrectal ultrasound scanning permits precise differentiation of the prostatic zones, in particular the transition zone, which is enlarged in BPH. Initially, a volume scan of the prostate is obtained. On the monitor, three sections of the prostate in the coronal, sagittal, and horizontal planes are displayed simultaneously. This new 3-D technology enables precise and reproducible positioning of the laser fibers at any selected site in the adenoma under sonographic guidance, thus providing the basis for complete laser prostatectomy. Placement of the laser fibers proved to be precise, quick, and uncomplicated.

Entities:  

Mesh:

Year:  1995        PMID: 8775083     DOI: 10.1089/end.1995.9.497

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  3 in total

1.  Three-dimensional transrectal ultrasound of the male urethral rhabdosphincter.

Authors:  H Strasser; G M Pinggera; C Gozzi; W Horninger; M Mitterberger; F Frauscher; G Bartsch
Journal:  World J Urol       Date:  2004-09-16       Impact factor: 4.226

Review 2.  [Transrectal three dimensional sonography. Techniques and indications].

Authors:  H Strasser; F Frauscher; A Klauser; M Mitterberger; G M Pinggera; P Rehder; R Herwig; G Bartsch
Journal:  Urologe A       Date:  2004-11       Impact factor: 0.639

3.  Interventional procedures in superficial lesions: the value of 2D with additional coronal reformatted 4D ultrasonography guidance.

Authors:  Cheng-Yen Chang; Hsin-Kai Wang; Hong-Jen Chiou; Yi-Hong Chou; Tain-Hsiung Chen; See-Ying Chiou
Journal:  Korean J Radiol       Date:  2006 Jan-Mar       Impact factor: 3.500

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.